A detailed history of Kepos Capital LP transactions in Albemarle Corp stock. As of the latest transaction made, Kepos Capital LP holds 1,586 shares of ALB stock, worth $141,391. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,586
Previous 1,536 3.26%
Holding current value
$141,391
Previous $147,000 2.04%
% of portfolio
0.07%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.85 - $100.09 $3,642 - $5,004
50 Added 3.26%
1,586 $150,000
Q2 2024

Aug 13, 2024

BUY
$92.77 - $135.46 $21,151 - $30,884
228 Added 17.43%
1,536 $147,000
Q1 2024

May 10, 2024

SELL
$108.73 - $146.89 $45,449 - $61,400
-418 Reduced 24.22%
1,308 $172,000
Q4 2023

Feb 12, 2024

BUY
$113.26 - $170.8 $72,939 - $109,995
644 Added 59.52%
1,726 $249,000
Q3 2023

Nov 13, 2023

SELL
$162.63 - $243.44 $6,017 - $9,007
-37 Reduced 3.31%
1,082 $184,000
Q2 2023

Aug 10, 2023

SELL
$172.91 - $232.22 $864 - $1,161
-5 Reduced 0.44%
1,119 $250,000
Q4 2022

Feb 13, 2023

BUY
$214.02 - $325.38 $17,763 - $27,006
83 Added 7.97%
1,124 $244,000
Q3 2022

Nov 14, 2022

SELL
$195.82 - $307.05 $57,766 - $90,579
-295 Reduced 22.08%
1,041 $275,000
Q2 2022

Aug 12, 2022

SELL
$187.76 - $270.92 $88,810 - $128,145
-473 Reduced 26.15%
1,336 $279,000
Q1 2022

May 13, 2022

SELL
$172.09 - $246.0 $7,055 - $10,086
-41 Reduced 2.22%
1,809 $400,000
Q4 2021

Feb 14, 2022

BUY
$214.16 - $283.8 $80,738 - $106,992
377 Added 25.59%
1,850 $432,000
Q3 2021

Nov 12, 2021

SELL
$167.91 - $244.03 $43,320 - $62,959
-258 Reduced 14.9%
1,473 $323,000
Q2 2021

Aug 12, 2021

BUY
$143.7 - $176.01 $91,824 - $112,470
639 Added 58.52%
1,731 $292,000
Q4 2020

Feb 12, 2021

BUY
$86.73 - $149.91 $29,401 - $50,819
339 Added 45.02%
1,092 $161,000
Q3 2020

Nov 13, 2020

BUY
$75.75 - $100.45 $57,039 - $75,638
753 New
753 $67,000

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $10.4B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Kepos Capital LP Portfolio

Follow Kepos Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Kepos Capital LP with notifications on news.